Biodesix

Since 2005, Biodesix has developed and commercialized blood-based tests that advance the speed and standard of care in oncology. Our diagnostics help patients and their doctors make more informed decisions about treatment based on a patient's unique molecular profile. We're advancing precision medicine by helping oncologists provide the right patient with the right treatment at the right time. Our two commercialized tests, VeriStrat® & GeneStrat™, offer results in 72 hours. No tissue is required. Our blood-based tests offer more complete information about the patient’s cancer
Type
Private
HQ
Boulder, US
Founded
2005
Employees
90 (est)+2%

Key People at Biodesix

Frank Ronchetti

Frank Ronchetti

CFO
Jim Purvis

Jim Purvis

Vice President of Human Resources and Operational Effectiveness
Jeffrey Bojar

Jeffrey Bojar

Vice President of Legal and Regulatory Affairs
Richard D. Hockett

Richard D. Hockett

Chief Medical Office
David Brunel

David Brunel

CEO
Paul Beresford

Paul Beresford

Vice President of Business Development and Strategic Marketing

Biodesix Locations

Boulder, US
Amargosa Valley, US

Biodesix Metrics

Biodesix Summary

Founding Date

2005

Total Funding

$117 M

Latest funding size

$22 M

Time since last funding

9 months

Biodesix Company Life

You may also be interested in